Electrochemical sensors detect depression-related metabolites in biofluids, suggesting a noninvasive screening method.
Multiplexed profiling of depression-related metabolites in biofluids is essential for precise screening. However, their vast concentration disparities challenge simultaneous detection using a single type of sensor. To address this challenge, this work presents an electrochemical flexible sensing strategy based on a PET/Ti/Au/AuNS/molecularly imprinted polymer (MIP) configuration. To ensure clinical relevance, the sensor’s linear ranges were tailored to align with physiological concentrations in biofluids. Supported by the fern-shaped Au nanostructures, the device achieves a detection range (1–100 μM, LOD = 0.612 μM) for l-tryptophan that covers human serum and sweat levels (15–40 μM). Furthermore, the sensor effectively monitors related metabolites with ranges optimized for their respective physiological baselines: 100–800 μM (LOD = 5.01 μM) for glutamine (encompassing healthy plasma levels of 550–750 μM) and a high-sensitivity range of 1–10 μM (LOD = 0.148 μM) for γ-aminobutyric acid to address its trace abundance in peripheral fluids due to the blood–brain barrier (0.1–0.6 mg/g in brain tissue). Building upon this, the fabricated integrated MIP-based flexible sensor successfully achieved simultaneous detection across disparate concentration gradients of key depression-related metabolites: l-tryptophan (3–100 μM), glutamine (100–800 μM), and γ-aminobutyric acid (1–8 μM) in artificial sweat. Furthermore, the sensor demonstrated reliable performance in real human sweat samples (retaining >76% of the signal compared to artificial sweat), validating its feasibility for practical, noninvasive health monitoring. This capability stems from the hierarchical fern-shaped Au nanostructures, which provide abundant MIP binding sites to significantly broaden the detection range. This integrated sensor offers a viable approach for depression screening and a strategy for simultaneously detecting multiple metabolites with wide concentration disparities in biofluids.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: